EZH2 as a Potential Target for NAFLD Therapy
Non-alcoholic fatty liver disease (NAFLD) is a complex disease that is affected by genetic predisposition and epigenetic modification. Deregulation of epigenetic pathways is now recognized as a frequent event in NAFLD, and understanding the mechanistic roles of these epigenetic factors may lead to n...
Main Authors: | Hyun Jung Lim, Mirang Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/22/8617 |
Similar Items
-
Mechanism and Progress of Natural Products in the Treatment of NAFLD-Related Fibrosis
by: Jin-Zhong Li, et al.
Published: (2023-12-01) -
Comparison between NAFLD fibrosis score and retinoic acid serum level in NAFLD
by: Ahmed Samir Allam, et al.
Published: (2020-01-01) -
EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies
by: Bohan Wang, et al.
Published: (2023-06-01) -
Targeting EZH2 in Multiple Myeloma—Multifaceted Anti-Tumor Activity
by: Mohammad Alzrigat, et al.
Published: (2018-09-01) -
Production, Exacerbating Effect, and EV-Mediated Transcription of Hepatic CCN2 in NASH: Implications for Diagnosis and Therapy of NASH Fibrosis
by: Xinlei Li, et al.
Published: (2023-08-01)